$2.4T
Total marketcap
$75.81B
Total volume
BTC 50.68%     ETH 14.94%
Dominance

Sangui Biotech SGBI Stock

0.0015 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
314.85K USD
LOW - HIGH [24H]
0.0015 - 0.0015 USD
VOLUME [24H]
200K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Sangui Biotech Price Chart

Sangui Biotech SGBI Financial and Trading Overview

Sangui Biotech stock price 0.0015 USD
Previous Close 0.002 USD
Open 0.004 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.004 - 0.02 USD
52 Week Range 0.002 - 0.02 USD
Volume 293.34K USD
Avg. Volume 6.06K USD
Market Cap 2.55M USD
Beta (5Y Monthly) 0.237164
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

SGBI Valuation Measures

Enterprise Value 591.42K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 31.476074
Price/Book (mrq) N/A
Enterprise Value/Revenue 7.314
Enterprise Value/EBITDA -5.198

Trading Information

Sangui Biotech Stock Price History

Beta (5Y Monthly) 0.237164
52-Week Change 49.75%
S&P500 52-Week Change 20.43%
52 Week High 0.02 USD
52 Week Low 0.002 USD
50-Day Moving Average 0.0041346 USD
200-Day Moving Average 0.00534025 USD

SGBI Share Statistics

Avg. Volume (3 month) 6.06K USD
Avg. Daily Volume (10-Days) 32.48K USD
Shares Outstanding 209.9M
Float 182.54M
Short Ratio N/A
% Held by Insiders 13.03%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin -154.22%
Operating Margin (ttm) -141.36%
Gross Margin 100.00%
EBITDA Margin -140.70%

Management Effectiveness

Return on Assets (ttm) -51.82%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 80.86K USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) 4.10%
Gross Profit (ttm) 69.19K USD
EBITDA -113771 USD
Net Income Avi to Common (ttm) -124702 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 6.98K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 834.05K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.038
Book Value Per Share (mrq) -0.002

Cash Flow Statement

Operating Cash Flow (ttm) -57875 USD
Levered Free Cash Flow (ttm) 9.81K USD

Profile of Sangui Biotech

Country United States
State N/A
City Hamburg
Address BleichenbrUecke 9
ZIP 20354
Phone 49 40 609 3120
Website https://www.sanguibiotech.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

Q&A For Sangui Biotech Stock

What is a current SGBI stock price?

Sangui Biotech SGBI stock price today per share is 0.0015 USD.

How to purchase Sangui Biotech stock?

You can buy SGBI shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Sangui Biotech?

The stock symbol or ticker of Sangui Biotech is SGBI.

Which industry does the Sangui Biotech company belong to?

The Sangui Biotech industry is Drug Manufacturers-Specialty & Generic.

How many shares does Sangui Biotech have in circulation?

The max supply of Sangui Biotech shares is 209.9M.

What is Sangui Biotech Price to Earnings Ratio (PE Ratio)?

Sangui Biotech PE Ratio is now.

What was Sangui Biotech earnings per share over the trailing 12 months (TTM)?

Sangui Biotech EPS is 0 USD over the trailing 12 months.

Which sector does the Sangui Biotech company belong to?

The Sangui Biotech sector is Healthcare.